Buy Temsujohn-D Online
Temsujohn-D is a combination of two components with complementary mechanisms of action that help eliminate symptoms in patients with benign prostatic hyperplasia (BPH): a dual inhibitor of 5α-reductase – dutasteride and an a1a-adrenergic receptor blocker – tamsulosin hydrochloride.
- Brand: Temsujohn-D
- Composition: 0.5 mg Dutasteride + 0.4 mg Tamsulosin
- Dosage form: Tablets
- Treatment: Enlarged Prostate / Symptoms Of BPH
- Manufacturer: Johnlee Pharmaceuticals Pvt. Ltd.
Temsujohn-D is an original combination drug for the treatment and prevention of benign prostatic hyperplasia.
Temsujohn-D Pill Review
Temsujohn-D tablet, which combines two active ingredients – dutasteride and tamsulosin, is a powerful remedy for the treatment of symptoms of benign prostatic hyperplasia (BPH).
What is the Temsujohn-D tablet used for?
Temsujohn-D tablet is used to treat and prevent the progression of benign prostatic hyperplasia by reducing its size, eliminating symptoms, increasing the rate of urination, reducing the risk of acute urinary retention and the need for surgery.
Dutasteride
Dutasteride suppresses the activity of isoenzymes 5α-reductase of the 1st and 2nd types, under the action of which testosterone is converted into 5α-dihydrotestosterone (DHT), the main androgen that causes hyperplasia of the glandular tissue of the prostate gland.
Tamsulosin
Tamsulosin inhibits a1a-adrenoreceptors in the smooth muscles of the prostate stroma and the neck of the bladder.Approximately 75% of the α1-adrenergic receptors in the prostate gland are receptors of the a1a subtype.
How does Temsujohn-D work?
- Dutasteride, as a 5-alpha reductase inhibitor, effectively reduces the level of dihydrotestosterone (DHT), a hormone that plays a key role in prostate enlargement. By reducing the production of DHT, dutasteride helps to reduce the size of the prostate gland and alleviate symptoms associated with its hyperplasia, such as difficulty urinating and frequent nocturnal urges.
- On the other hand, tamsulosin, which is an alpha-adrenoblocker, relaxes the smooth muscles of the prostate gland and the neck of the bladder. This reduces the resistance to urine flow and facilitates the urination process. It works quickly, providing patients with significant relief of symptoms within a few days after the start of admission.
Combination therapy with dutasteride and tamsulosin provides a comprehensive approach to managing the symptoms of BPH. While dutasteride solves the problem on a hormonal level by acting on the underlying cause of prostate enlargement, tamsulosin provides immediate relief by relieving muscle tension and improving urine flow.
A tablet with a combination of Dutasteride and Tamsulosin
Modern advances in pharmacology provide effective and convenient solutions for patients with BPH. A tablet with a combination of dutasteride and tamsulosin is a vivid example of this approach, combining the advantages of two powerful drugs to achieve the best therapeutic result.
This combination therapy has proven effective in numerous clinical studies and has become the preferred option for many doctors treating patients with moderate to severe symptoms of BPH. It allows not only to improve the quality of life of the patient, but also to reduce the need for surgical intervention.
How to use a Temsujohn-D pill?
Adult men (including elderly patients):
The recommended dose of Temsujohn-D is one tablet orally once a day, approximately 30 minutes after the same meal.
Tablet should be washed down with water. Tablet should be taken whole, without chewing or opening. Contact of the contents of a soft gelatin capsule containing dutasteride, which is contained inside a hard tablet, with the mucous membrane of the oral cavity can cause inflammatory phenomena on the part of the mucous membrane.
Description of Temsujohn-D tablet
To date, combination therapy with Temsujohn-D tablet dutasteride and tamsulosin represents an important step forward in the treatment of benign prostatic hyperplasia. They allow patients to avoid prolonged periods of discomfort and reduce the risk of serious complications associated with progressive hyperplasia. Thanks to this combination, many men can lead a normal lifestyle without experiencing constant difficulties with urination and other symptoms of BPH.
The advantage of such therapy is also to reduce the overall burden on the patient’s body. Previously, to achieve such an effect, it would have been necessary to take several different drugs, each of which would have its own side effects and the need for regular monitoring. The combined drug is a single tablet, which simplifies the treatment process and increases the chance for the patient to comply with prescribed regimens.
New research is constantly being conducted to optimize therapy and find the best combinations of dosages and formulas. Scientists are trying to find ways to minimize side effects and improve the effectiveness of treatment. The development of standard protocols for the use of such combined drugs is also aimed at improving the condition of patients and reducing the need for surgical interventions. In light of these advances, the future of BPH treatment looks promising, offering patients an improved quality of life and more opportunities for active and healthy aging.
